Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Frequently asked questions
What is the patient guides?
It is plain-language guides to GLP-1 pricing, comparison, and treatment basics. Every page is reviewed against our published pricing methodology.
How does GLP-1 Price Guide compare providers?
We score providers on true monthly cost, pharmacy transparency, provider oversight, shipping, dose policy, and marketing honesty — not the advertised starter price.
Why does true monthly cost matter more than the starter price?
Many programs advertise a low first-month price, then charge more at maintenance dose or add membership and shipping fees. True monthly cost reflects what you actually pay long term.
Are compounded GLP-1 medications FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How often is pricing updated?
Pricing is re-verified monthly from publicly available provider pages and dated third-party sources, and labeled with a confidence status.